Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVANOS MEDICAL, INC. Director's Dealing 2021

Dec 21, 2021

32765_dirs_2021-12-21_4d486861-03fd-4123-9f50-0382e4462d60.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avanos Medical, Inc. (AVNS)
CIK: 0001606498
Period of Report: 2021-12-17

Reporting Person: Ball David Edward (SVP - Global Supply Chain)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-12-17 Common Stock F 1411 $31.22 Disposed 11600 Direct

Footnotes

F1: (1) Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of restricted share units awarded to the Reporting Person on 12/17/2018 with a 3-year cliff vesting period.